VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Profit After Tax (2010 - 2026)

VivoSim Labs (VIVS) posted quarterly Profit After Tax of -$5.8 million for Q1 2026, down 184.12% year-over-year from $6.9 million in Q1 2025, and down 114.2% quarter-over-quarter from -$2.7 million in Q4 2025.

VivoSim Labs (VIVS) Profit After Tax (2010 - 2026) Analysis & Trends

VivoSim Labs' Profit After Tax history runs 17 years deep, the most recent figure standing at -$5.8 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 184.12% year-over-year to -$5.8 million; the TTM figure through Mar 2026 stood at -$13.8 million (down 456.39% YoY), while the FY2026 annual figure was -$13.8 million, down 456.39% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$5.8 million, down from -$2.7 million in the prior quarter.
  • The five-year high for Profit After Tax was $6.9 million in Q1 2025, with the low at -$7.5 million in Q1 2023.
  • The 5-year median for Profit After Tax is -$3.3 million (2022), against an average of -$3.0 million.
  • The sharpest annual moves came in 2023 and 2025: Profit After Tax tumbled 290.37% in 2023, then soared 324.88% in 2025.
  • VivoSim Labs' Profit After Tax stood at -$3.3 million in 2022, then decreased by 10.42% to -$3.6 million in 2023, then rose by 4.36% to -$3.4 million in 2024, then grew by 21.93% to -$2.7 million in 2025, then tumbled by 114.2% to -$5.8 million in 2026.
  • Business Quant data shows VIVS's Profit After Tax at -$5.8 million in Q1 2026, -$2.7 million in Q4 2025, and -$2.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 VivoSim Labs 1.49 Mn 1.49 Mn - -1.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.34 Mn
Mar 31, 2026 -5.76 Mn
Dec 31, 2025 -2.69 Mn
Sep 30, 2025 -2.55 Mn
Jun 30, 2025 -2.84 Mn
Mar 31, 2025 6.85 Mn
Dec 31, 2024 -3.45 Mn
Sep 30, 2024 -2.55 Mn
Jun 30, 2024 -3.34 Mn
Mar 31, 2024 -3.05 Mn
Dec 31, 2023 -3.60 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 -4.03 Mn
Mar 31, 2023 -7.46 Mn
Dec 31, 2022 -3.26 Mn
Sep 30, 2022 -3.32 Mn
Jun 30, 2022 -3.22 Mn
Mar 31, 2022 -1.91 Mn
Dec 31, 2021 -3.50 Mn
Sep 30, 2021 -3.51 Mn